Clinical trial
Harmonizing RCT-Duplicate Emulations In A Real World Replication Program (HARRP)
NCT06099067
Study timeline
Study start (actual)2020-05-15Date precision: day
Registry last updated2024-08-30
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Type 2 Diabetes Mellitusunresolved
Interventions
CanagliflozinDRUG · verified · RxNorm: canagliflozin
DPP4 inhibitorDRUG
LiraglutideDRUG · verified · RxNorm: liraglutide
SaxagliptinDRUG · verified · RxNorm: saxagliptin
Sponsors & collaborators
AstraZenecalead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06099067 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.